Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hee Cheol Kim

Showing results (321-330 of 331) with videos related to

Pageof 34
Sort By:
Oncotarget|September 17, 2015
Gastrointestinal malignancies harbor actionable MET exon 14 deletionsJeeyun Lee, Sai-Hong Ignatius Ou, Ji Min Lee, et al.
Investigational New Drugs|January 29, 2014
Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximabJeeyun Lee, Yong Sang Hong, Jung Yong Hong, et al.
The Oncologist|July 14, 2017
Clinical Application of Targeted Deep Sequencing in Solid-Cancer Patients and Utility for Biomarker-Selected Clinical TrialsSeung Tae Kim, Kyoung-Mee Kim, Nayoung K D Kim, et al.
BMB Reports|November 20, 2025
Transcriptomic analysis of colorectal carcinoma tissues from a Korean populationHoang Bao Khanh Chu, Ji Hye Choi, Jongbum Jeon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 30, 2022
Oxaliplatin (3 months <i>v</i> 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07Seung Tae Kim, Sun Young Kim, Jeeyun Lee, et al.
Oncotarget|July 15, 2015
Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screeningJeeyun Lee, Hee Cheol Kim, Jung Yong Hong, et al.
Oncotarget|September 24, 2015
The NEXT-1 (Next generation pErsonalized tX with mulTi-omics and preclinical model) trial: prospective molecular screening trial of metastatic solid cancer patients, a feasibility analysisSeung Tae Kim, Jeeyun Lee, Mineui Hong, et al.
BMB Reports|August 22, 2023
Comprehensive profiling of DNA methylation in Korean patients with colorectal cancerHyeran Shim, Kiwon Jang, Yeong Hak Bang, et al.
Nature Communications|November 11, 2017
Prevalence and detection of low-allele-fraction variants in clinical cancer samplesHyun-Tae Shin, Yoon-La Choi, Jae Won Yun, et al.
Nature Genetics|May 27, 2020
Lineage-dependent gene expression programs influence the immune landscape of colorectal cancerHae-Ock Lee, Yourae Hong, Hakki Emre Etlioglu, et al.
Pageof 34

Showing results (321-330 of 331) with videos related to

Sort By:
Pageof 34
Oncotarget|September 17, 2015
Gastrointestinal malignancies harbor actionable MET exon 14 deletionsJeeyun Lee, Sai-Hong Ignatius Ou, Ji Min Lee, et al.
Investigational New Drugs|January 29, 2014
Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximabJeeyun Lee, Yong Sang Hong, Jung Yong Hong, et al.
The Oncologist|July 14, 2017
Clinical Application of Targeted Deep Sequencing in Solid-Cancer Patients and Utility for Biomarker-Selected Clinical TrialsSeung Tae Kim, Kyoung-Mee Kim, Nayoung K D Kim, et al.
BMB Reports|November 20, 2025
Transcriptomic analysis of colorectal carcinoma tissues from a Korean populationHoang Bao Khanh Chu, Ji Hye Choi, Jongbum Jeon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 30, 2022
Oxaliplatin (3 months <i>v</i> 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07Seung Tae Kim, Sun Young Kim, Jeeyun Lee, et al.
Oncotarget|July 15, 2015
Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screeningJeeyun Lee, Hee Cheol Kim, Jung Yong Hong, et al.
Oncotarget|September 24, 2015
The NEXT-1 (Next generation pErsonalized tX with mulTi-omics and preclinical model) trial: prospective molecular screening trial of metastatic solid cancer patients, a feasibility analysisSeung Tae Kim, Jeeyun Lee, Mineui Hong, et al.
BMB Reports|August 22, 2023
Comprehensive profiling of DNA methylation in Korean patients with colorectal cancerHyeran Shim, Kiwon Jang, Yeong Hak Bang, et al.
Nature Communications|November 11, 2017
Prevalence and detection of low-allele-fraction variants in clinical cancer samplesHyun-Tae Shin, Yoon-La Choi, Jae Won Yun, et al.
Nature Genetics|May 27, 2020
Lineage-dependent gene expression programs influence the immune landscape of colorectal cancerHae-Ock Lee, Yourae Hong, Hakki Emre Etlioglu, et al.
Pageof 34